Safety and Efficacy of AON-D21 in Severe Community-Acquired Pneumonia.
Aptarion Biotech AG
Aptarion Biotech AG
Weill Medical College of Cornell University
Hospices Civils de Lyon
Brigham and Women's Hospital
RenJi Hospital
University of Sydney
National Cancer Institute (NCI)
University Hospital Schleswig-Holstein
The Cooper Health System
Duke-NUS Graduate Medical School
University of Zurich
Central TB Research Institute
BioAegis Therapeutics Inc.
University Hospital Augsburg
Mayo Clinic
M.D. Anderson Cancer Center
Azienda Sanitaria-Universitaria Integrata di Udine
AstraZeneca
National Institute for Tuberculosis and Lung Diseases, Poland
Nantes University Hospital
Guangzhou Institute of Respiratory Disease
National Heart, Lung, and Blood Institute (NHLBI)
Milton S. Hershey Medical Center
M.D. Anderson Cancer Center
Lata Medical Research Foundation, Nagpur
MedImmune LLC
Kaiser Permanente